These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 7323819)
21. [Radiomodifiers and the progress of radiation oncology]. Iarmonenko SP Vopr Onkol; 1995; 41(2):93-4. PubMed ID: 7483456 [No Abstract] [Full Text] [Related]
22. [The role of radiotherapy in the treatment of lung cancer]. Van Houtte P Rev Med Brux; 1985 Jun; 6(6):397-403. PubMed ID: 4035139 [No Abstract] [Full Text] [Related]
23. Interaction of drugs and radiation - promise or pitfall? Berry RJ Clin Radiol; 1982 Mar; 33(2):121-9. PubMed ID: 7039938 [No Abstract] [Full Text] [Related]
24. Radiobiological modifiers in clinical radiation oncology: current reality and future potential. Allison RR Future Oncol; 2014 Dec; 10(15):2359-79. PubMed ID: 25525845 [TBL] [Abstract][Full Text] [Related]
25. International Clinical Trials in Radiation Oncology. Chemical modifiers. Bartelink H; Bleehen NM; Phillips TL Int J Radiat Oncol Biol Phys; 1988; 14 Suppl 1():S39-49. PubMed ID: 3292481 [No Abstract] [Full Text] [Related]
26. Chemical radiation sensitizers and protectors: recent developments. Kim JH; Chu FC Clin Bull; 1981; 11(1):5-11. PubMed ID: 6268335 [No Abstract] [Full Text] [Related]
27. [Restorative inhibition of radiation injureis by chemical compounds as a method of increasing the effectiveness of the radiotherapy of tumors]. Pelevina II Med Radiol (Mosk); 1977 Feb; 22(2):8-13. PubMed ID: 859396 [No Abstract] [Full Text] [Related]
28. [Amifostine as a supporting treatment during cancer therapy]. Jantunen E; Puistola U Duodecim; 1999; 115(11):1223-7. PubMed ID: 11877841 [No Abstract] [Full Text] [Related]
29. Conference on chemical modification: radiation and cytotoxic drugs. Key Biscayne, Florida, 17-20 September, 1981. Int J Radiat Oncol Biol Phys; 1982; 8(3-4):323-815. PubMed ID: 7107349 [No Abstract] [Full Text] [Related]
30. Modification of radiotherapy by radiosensitizers and cancer chemotherapy agents. I. Radiosensitizers. Coleman CN Semin Oncol; 1989 Jun; 16(3):169-75. PubMed ID: 2658080 [No Abstract] [Full Text] [Related]
34. Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers. Harrington KJ; Billingham LJ; Brunner TB; Burnet NG; Chan CS; Hoskin P; Mackay RI; Maughan TS; Macdougall J; McKenna WG; Nutting CM; Oliver A; Plummer R; Stratford IJ; Illidge T Br J Cancer; 2011 Aug; 105(5):628-39. PubMed ID: 21772330 [No Abstract] [Full Text] [Related]
35. Carcinogenic, mutagenic, teratogenic workshop. Suit H; Hall E; Frei E Cancer Clin Trials; 1981; 4 Suppl():37-41. PubMed ID: 7307224 [No Abstract] [Full Text] [Related]
36. [Randomizations!]. Piedbois P; Buyse M Cancer Radiother; 1998 Dec; 2(6):663-4. PubMed ID: 9922769 [No Abstract] [Full Text] [Related]
37. Can the therapeutic gain of radiotherapy be increased by concurrent administration of Asian botanicals? Sagar SM Integr Cancer Ther; 2010 Mar; 9(1):5-13. PubMed ID: 20042406 [TBL] [Abstract][Full Text] [Related]
38. Response to "Radiation therapeutic gain and Asian botanicals," by Stephen Sagar. Lawenda BD Integr Cancer Ther; 2010 Mar; 9(1):14-5. PubMed ID: 20308083 [TBL] [Abstract][Full Text] [Related]
39. [A review. Current problems of experimental and clinical radiotherapy]. Merkle K Arch Geschwulstforsch; 1987; 57(1):69-79. PubMed ID: 3551869 [TBL] [Abstract][Full Text] [Related]